AS
PRVL

Altshuler Shaham’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Altshuler Shaham’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-51,933
Closed -$1.2M – 562
2020
Q4 		$1.2M Hold
51,933
– – 0.02% 64
2020
Q3 		$529K Hold
51,933
– – 0.01% 118
2020
Q2 		$774K Hold
51,933
– – 0.02% 79
2020
Q1 		$633K Buy
51,933
+1,473
+3% +$23.4K 0.03% 74
2019
Q4 		$799K Hold
50,460
– – 0.02% 83
2019
Q3 		$615K Buy
+50,460
New +$572K 0.02% 87

Altshuler Shaham's PRVL Position: Q1 2021 in Review

Altshuler Shaham sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 51,933 shares — an estimated $1.2M sold.

Altshuler Shaham first reported a position in PRVL in Q3 2019 and held it in 6 quarters. The position peaked at $1.2M in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

  • Altshuler Shaham reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Altshuler Shaham sold 51,933 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $1.2M.
  • Altshuler Shaham first reported a position in Prevail Therapeutics Inc. Common Stock in Q3 2019 and held it in 6 quarters.
  • Altshuler Shaham's Prevail Therapeutics Inc. Common Stock position peaked at $1.2M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on Altshuler Shaham's 13F filing for Q1 2021, filed 13 May 2021.